✦ LIBER ✦

Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-α and the epidermal growth factor receptor

✍ Scribed by Marvin Rubenstein; Roberta Glick; Terry Lichtor; Yelena Mirochnik; Pauline Chou; Patrick Guinan

Book ID: 111640824
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 305 KB
Volume: 18
Category: Article
ISSN: 1357-0560
DOI: 10.1385/mo:18:2:121

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of type beta transforming gr

The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line

✍ Eirik Helseth; Geirmund Unsgaard; Are Dalen; Randi Vik 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 582 KB

Type beta transforming growth factor (B-TGF) is a potent growth inhibitor to many human tumor cell lines. Very little is known about the mechanism for this growth inhibitory action of B-TGF. We here report the effect of B-TGF on proliferation and epidermal growth factor receptor (R-EGF) expression i

Combination treatment of glioblastoma mu

Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774

✍ Thomas Efferth; Tzutzuy Ramirez; Erich Gebhart; Marc-Eric Halatsch 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Quantitative immunohistochemical analysi

Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck: J. R. Grandis, M. F. Melhem, E. L. Barnes, D. J. Tweardy Cancer 1996: 78: 1284–92

✍ H. Tideman 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 179 KB

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION TESTING AND FIRST LINE TREATMENT WITH GEFITINIB IS A DOMINANT STRATEGY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

✍ G. de Lima Lopes 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCN17 Indirect Comparison of the Efficac

PCN17 Indirect Comparison of the Efficacy of Erlotinib Versus Pemetrexed Plus Cisplatin as First Line Treatment in Patients With Metastatic Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating Mutations

✍ C. Pereira; M. Sanches; J.F. Loff 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB